|
1
|
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.
|
Nat Med
|
2003
|
5.97
|
|
2
|
Neonatal adaptive immunity comes of age.
|
Nat Rev Immunol
|
2004
|
5.31
|
|
3
|
Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils.
|
Immunity
|
2009
|
3.52
|
|
4
|
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence.
|
Infect Immun
|
2006
|
2.56
|
|
5
|
Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP.
|
PLoS Pathog
|
2008
|
1.94
|
|
6
|
Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity.
|
J Immunol
|
2002
|
1.88
|
|
7
|
Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis.
|
Nat Genet
|
2013
|
1.67
|
|
8
|
Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs.
|
Immunity
|
2005
|
1.66
|
|
9
|
Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity.
|
J Biol Chem
|
2005
|
1.64
|
|
10
|
Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system.
|
J Immunol
|
2005
|
1.61
|
|
11
|
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
|
Infect Immun
|
2006
|
1.51
|
|
12
|
CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules.
|
J Exp Med
|
2002
|
1.49
|
|
13
|
Developing a model of recovery in mental health.
|
BMC Health Serv Res
|
2009
|
1.40
|
|
14
|
Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation.
|
Mol Microbiol
|
2012
|
1.39
|
|
15
|
Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells.
|
J Exp Med
|
2007
|
1.39
|
|
16
|
Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.
|
Bioconjug Chem
|
2005
|
1.36
|
|
17
|
Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.
|
Blood
|
2008
|
1.32
|
|
18
|
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6.
|
Infect Immun
|
2004
|
1.31
|
|
19
|
Ontogeny and innate properties of neonatal dendritic cells.
|
Blood
|
2003
|
1.30
|
|
20
|
High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
|
Infect Immun
|
2006
|
1.26
|
|
21
|
A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates.
|
Cancer Res
|
2004
|
1.26
|
|
22
|
Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN.
|
J Immunol
|
2007
|
1.25
|
|
23
|
Predictors and profiles of treatment non-adherence and engagement in services problems in early psychosis.
|
Schizophr Res
|
2008
|
1.20
|
|
24
|
CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family.
|
Infect Immun
|
2003
|
1.18
|
|
25
|
The T-cell receptor repertoire of tumor-infiltrating regulatory T lymphocytes is skewed toward public sequences.
|
Cancer Res
|
2012
|
1.17
|
|
26
|
Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation.
|
Blood
|
2004
|
1.17
|
|
27
|
In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway.
|
J Immunol
|
2003
|
1.16
|
|
28
|
Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: Role of toxin acylation and identification of the main integrin interaction domain.
|
J Biol Chem
|
2003
|
1.15
|
|
29
|
Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
|
J Infect Dis
|
2004
|
1.13
|
|
30
|
Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system.
|
Cancer Res
|
2007
|
1.11
|
|
31
|
ESAT-6 secretion-independent impact of ESX-1 genes espF and espG1 on virulence of Mycobacterium tuberculosis.
|
J Infect Dis
|
2010
|
1.09
|
|
32
|
The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo.
|
J Immunol
|
2007
|
1.08
|
|
33
|
Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.
|
J Immunol
|
2004
|
1.06
|
|
34
|
Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
|
Vaccine
|
2008
|
1.05
|
|
35
|
TLR3 ligand stimulates fully functional memory CD8+ T cells in the absence of CD4+ T-cell help.
|
Blood
|
2007
|
1.04
|
|
36
|
Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein.
|
Cancer Res
|
2005
|
1.03
|
|
37
|
Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial.
|
J Nerv Ment Dis
|
2008
|
1.01
|
|
38
|
Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potential.
|
Cell Host Microbe
|
2012
|
1.01
|
|
39
|
Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cells.
|
J Immunol
|
2002
|
1.01
|
|
40
|
Regulatory B and T cells in infections.
|
Microbes Infect
|
2008
|
1.01
|
|
41
|
Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis.
|
PLoS One
|
2008
|
1.00
|
|
42
|
Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector.
|
Clin Vaccine Immunol
|
2007
|
0.98
|
|
43
|
Acylation of lysine 860 allows tight binding and cytotoxicity of Bordetella adenylate cyclase on CD11b-expressing cells.
|
Biochemistry
|
2005
|
0.98
|
|
44
|
Virus-like particles: a new family of delivery systems.
|
Expert Rev Vaccines
|
2002
|
0.96
|
|
45
|
New tools for antigen delivery to the MHC class I pathway.
|
Trends Immunol
|
2004
|
0.96
|
|
46
|
Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids.
|
Infect Immun
|
2005
|
0.95
|
|
47
|
Recognition of mycobacterial antigens delivered by genetically detoxified Bordetella pertussis adenylate cyclase by T cells from cattle with bovine tuberculosis.
|
Infect Immun
|
2004
|
0.93
|
|
48
|
Delivery of a MalE CD4(+)-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase.
|
Infect Immun
|
2002
|
0.92
|
|
49
|
MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion.
|
J Leukoc Biol
|
2013
|
0.90
|
|
50
|
Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
|
J Virol
|
2005
|
0.90
|
|
51
|
The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.
|
Int J Med Microbiol
|
2004
|
0.90
|
|
52
|
The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization.
|
Int Immunol
|
2003
|
0.89
|
|
53
|
Carbohydrate antigens: synthesis aspects and immunological applications in cancer.
|
Mini Rev Med Chem
|
2006
|
0.89
|
|
54
|
In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells.
|
Eur J Immunol
|
2002
|
0.88
|
|
55
|
CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particles.
|
Virology
|
2003
|
0.88
|
|
56
|
Adenylate cyclase toxin translocates across target cell membrane without forming a pore.
|
Mol Microbiol
|
2010
|
0.88
|
|
57
|
Purification of splenic dendritic cells induces maturation and capacity to stimulate Th1 response in vivo.
|
Int Immunol
|
2006
|
0.87
|
|
58
|
Induction of protective antiviral cytotoxic T cells by a tubular structure capable of carrying large foreign sequences.
|
Vaccine
|
2002
|
0.87
|
|
59
|
Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheres.
|
J Immunol
|
2004
|
0.86
|
|
60
|
Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses.
|
J Biol Chem
|
2010
|
0.86
|
|
61
|
The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.
|
Cancer Res
|
2009
|
0.86
|
|
62
|
Induction of HLA-A2-restricted CTL responses by a tubular structure carrying human melanoma epitopes.
|
Vaccine
|
2002
|
0.85
|
|
63
|
The shift of Th1 to Th2 immunodominance associated with the chronicity of Mycobacterium bovis bacille Calmette-Guérin infection does not affect the memory response.
|
J Immunol
|
2003
|
0.85
|
|
64
|
Personality characteristics and attachment in first episode psychosis: impact on social functioning.
|
J Nerv Ment Dis
|
2007
|
0.85
|
|
65
|
Fetal spleen stroma drives macrophage commitment.
|
Development
|
2006
|
0.85
|
|
66
|
Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.
|
Cancer Immunol Immunother
|
2013
|
0.85
|
|
67
|
Cross-priming of T cell responses by synthetic microspheres carrying a CD8+ T cell epitope requires an adjuvant signal.
|
J Immunol
|
2005
|
0.85
|
|
68
|
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin.
|
Int J Cancer
|
2011
|
0.85
|
|
69
|
Neonatal plasmacytoid dendritic cells (pDCs) display subset variation but can elicit potent anti-viral innate responses.
|
PLoS One
|
2013
|
0.85
|
|
70
|
Inhibition of phagosome maturation by mycobacteria does not interfere with presentation of mycobacterial antigens by MHC molecules.
|
J Immunol
|
2007
|
0.85
|
|
71
|
Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.
|
Int Immunol
|
2003
|
0.85
|
|
72
|
Calcium influx rescues adenylate cyclase-hemolysin from rapid cell membrane removal and enables phagocyte permeabilization by toxin pores.
|
PLoS Pathog
|
2012
|
0.85
|
|
73
|
Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.
|
Glycobiology
|
2006
|
0.84
|
|
74
|
Processing of the bovine spongiform encephalopathy-specific prion protein by dendritic cells.
|
J Virol
|
2006
|
0.84
|
|
75
|
Pivotal role of plasmacytoid dendritic cells in inflammation and NK-cell responses after TLR9 triggering in mice.
|
Blood
|
2012
|
0.84
|
|
76
|
Induction of anti-Tat neutralizing antibodies by the CyaA vector targeting dendritic cells: influence of the insertion site and of the delivery of multicopies of the dominant Tat B-cell epitope.
|
Vaccine
|
2010
|
0.82
|
|
77
|
Group CBT for early psychosis--are there still benefits one year later?
|
Int J Group Psychother
|
2012
|
0.82
|
|
78
|
Change in jumping to conclusions linked to change in delusions in early psychosis.
|
Schizophr Res
|
2013
|
0.81
|
|
79
|
Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant.
|
Blood
|
2010
|
0.81
|
|
80
|
Do people with a first episode of psychosis differ in personality profiles?
|
Schizophr Res
|
2006
|
0.81
|
|
81
|
Spirituality and religion in outpatients with schizophrenia: a multi-site comparative study of Switzerland, Canada, and the United States.
|
Int J Psychiatry Med
|
2012
|
0.81
|
|
82
|
The adjuvant effect of TLR agonists on CD4(+) effector T cells is under the indirect control of regulatory T cells.
|
Eur J Immunol
|
2011
|
0.80
|
|
83
|
Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses.
|
Vaccine
|
2012
|
0.79
|
|
84
|
Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen.
|
Bioorg Med Chem Lett
|
2004
|
0.78
|
|
85
|
Treatment by CpG or Flt3-ligand does not affect mouse susceptibility to BSE prions.
|
J Neuroimmunol
|
2008
|
0.78
|
|
86
|
Complexes of streptavidin-fused antigens with biotinylated antibodies targeting receptors on dendritic cell surface: a novel tool for induction of specific T-cell immune responses.
|
Mol Biotechnol
|
2012
|
0.78
|
|
87
|
Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates.
|
Vaccine
|
2006
|
0.78
|
|
88
|
Do personality traits matter when choosing a group therapy for early psychosis?
|
Psychol Psychother
|
2011
|
0.77
|
|
89
|
Personality traits in early psychosis: relationship with symptom and coping treatment outcomes.
|
Early Interv Psychiatry
|
2010
|
0.76
|
|
90
|
The process of recovery of people with mental illness: the perspectives of patients, family members and care providers: part 1.
|
BMC Health Serv Res
|
2010
|
0.76
|
|
91
|
Religion and spirituality: how clinicians in quebec and geneva cope with the issue when faced with patients suffering from chronic psychosis.
|
Community Ment Health J
|
2009
|
0.76
|
|
92
|
Intrusion errors in explicit memory: their differential relationship with clinical and social outcome in chronic schizophrenia.
|
Cogn Neuropsychiatry
|
2007
|
0.76
|
|
93
|
Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.
|
Vaccine
|
2004
|
0.76
|
|
94
|
Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis.
|
Vaccine
|
2010
|
0.75
|
|
95
|
Challenges and issues in new vaccine development.
|
Trends Immunol
|
2002
|
0.75
|
|
96
|
[Analysis of in vitro delivering CD8+ T epitopes by attenuated bacteria].
|
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
|
2006
|
0.75
|
|
97
|
[In-vivo dynamic changes of antigen presenting cells infected with recombinant attenuated Salmonella typhimurium expressing green fluorescent protein].
|
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
|
2003
|
0.75
|
|
98
|
[Group interventions for people with refractory psychosis].
|
Sante Ment Que
|
2005
|
0.75
|
|
99
|
[Reaction of nurses to telephone clients with borderline personality disorder].
|
Perspect Infirm
|
2012
|
0.75
|
|
100
|
[Evaluation of the mental condition. How are you today?].
|
Perspect Infirm
|
2011
|
0.75
|